Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04332692

Acute Heart Failure - COngestion Discharge Evaluation

Acute Heart Failure - COngestion Discharge Evaluation. Évaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of death or re-hospitalisation at 3 months. This risk is significantly increased by insufficient decongestion at the end of hospitalisation for AHF assessed by a standardised clinical score, a natriuretic peptide dosage or by cardiac and pulmonary ultrasound . Adapting treatment according to lung congestion assessed by implantable devices (not reimbursed in France) improves the prognosis. However, due to the lack of a standardised congestion assessment, therapeutic adaptation in acute heart failure is currently empirical. The best multimodality approach to congestion evaluation is uncertain.

Conditions

Interventions

TypeNameDescription
PROCEDUREClinical examination centered on congestionClinical examination centered on congestion (ASCEND, NYHA and Ambrosy Score) will be performed before discharge from hospital
PROCEDURECardiac, pulmonary, peritoneal, jugular, renal Doppler ultrasounds and liver elastographyCardiac, pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography will be performed before discharge from hospital
PROCEDUREBlood sample retrieved for biological assessment and biobankingBlood sample retrieved for biological assessment and biobanking will be performed before discharge from hospital
PROCEDURETelephone follow-upTelephone follow-up will be performed 3, 12 and 24 months after discharge from hospital
BEHAVIORALKansas City Cardiomyopathy Questionnaire (KCCQ)Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge

Timeline

Start date
2020-07-15
Primary completion
2026-08-20
Completion
2028-05-20
First posted
2020-04-03
Last updated
2023-06-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04332692. Inclusion in this directory is not an endorsement.